Digital Media Briefs: AgaMatrix, WaveSense, Corbett Accel, Twitter and Sudler & Hennessey

Share this article:
AgaMatrix, which makes the WaveSense line of blood glucose monitoring products, announced that the latest version of its WaveSense Diabetes Manager App will provide users with streaming video content from dLife. The app is available through free download at the iTunes Store.

Geoffrey Melick, formerly of Corbett Accel, joined Tribune Company as SVP health, in which he will head health advertising and oversee Healthkey.com. Melick was EVP/interactive marketing and e-innovation at Corbett Accel. Tribune publishes The Chicago Tribune and The LA Times, along with several other newspapers, and operates a broadcast mini-empire.

Has Twitter jumped the shark? Figures from data firms Compete and Quantcast suggest that it may have plateaued stateside, with US unique users having peaked around mid-year and inched down since. Outside the US, however, the number of unique users continues to soar.

Sudler & Hennessey hired Shane Kennedy as EVP, managing director of Sudler Digital. Kennedy was director of US marketing & business development for Elateral in London and chief marketing officer for Conclusive Marketing.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?